These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10736908)

  • 1. Risk stratification in the management of atrial fibrillation in the community.
    Fahey T; Rimmer J; Godfrey P
    Br J Gen Pract; 1999 Apr; 49(441):295-6. PubMed ID: 10736908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
    Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
    Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
    Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
    de Lusignan S; van Vlymen J; Hague N; Thana L; Dzregah B; Chan T
    J Public Health (Oxf); 2005 Mar; 27(1):85-92. PubMed ID: 15590708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in atrial fibrillation.
    Anderson M; Kirk M
    Med Health R I; 2004 Apr; 87(4):98-100. PubMed ID: 15168633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based study of atrial fibrillation and stroke prevention.
    White S; Feely J; O'Neill D
    Ir Med J; 2004 Jan; 97(1):10-2. PubMed ID: 15055913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM; Boom K; Jackson SL; Vial JH
    Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation.
    Ebell MH
    Am Fam Physician; 2005 Jun; 71(12):2348-50. PubMed ID: 15999873
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL; Corbett TL
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention.
    Bajorek BV; Krass I; Ogle SJ; Duguid MJ; Shenfield GM
    J Am Geriatr Soc; 2005 Nov; 53(11):1912-20. PubMed ID: 16274372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
    Connolly SJ
    Am Heart J; 2003 Mar; 145(3):418-23. PubMed ID: 12660663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing patterns for the use of antithrombotics in the management of atrial fibrillation in Zimbabwe.
    Bhagat K; Tisocki K
    Cent Afr J Med; 1999 Nov; 45(11):287-90. PubMed ID: 10892453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Capucci A; Lip GY; Olsson SB; Prins MH; Nieman FH; López-Sendón J; Vardas PE; Aliot E; Santini M; Crijns HJ;
    Eur Heart J; 2006 Dec; 27(24):3018-26. PubMed ID: 16731536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
    Han W; Shen DT; Wang YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):851-2, 855. PubMed ID: 16793618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.